Abstract
The majority of data on risk factors (RFs) for hepatocellular carcinoma (HCC) comes from studies involving populations without underlying liver disease. It is important to evaluate RFs for HCC in patients with chronic liver disease since HCC rarely occurs in those without underlying liver disease. We conducted a hospital-based case–control study of 259 incident HCC cases and 781 controls by convenience sampling between 02/2001 and 12/2009 from the liver clinic at Stanford University Medical Center. The study population was 41% White, 14% Hispanic, 3% African American, 40% Asian American, and 2% other race/ethnicity. RFs were examined through medical records and an in-person questionnaire. Alcohol and tobacco use was calculated by cumulative grams of alcohol or cumulative pack(s) of cigarette consumed over one’s lifetime. Diabetes mellitus (DM) was defined by random glucose level of ≥200 mg/dL. RFs were evaluated using multivariate logistic regression. Independent predictors of HCC risk, after mutual adjustment and additional control for alcohol use, etiology of liver diseases, and DM, included age >40 (OR = 8.5 [2.6–28.3]), male gender (OR = 3.5 [2.2–5.8]), presence of cirrhosis (OR = 2.8 [1.6–4.9]), Asian ethnicity (OR = 2.8 [1.8–4.6]), AFP > 50 (OR = 4.2 [2.6–6.8]), and cumulative lifetime tobacco use of >11,000 packs (OR = 1.7 [1.0–2.9]). Heavy prolonged cigarette smoking, but not alcohol use, was a significant independent predictor for HCC in patients with underlying liver disease. Besides older age, male gender, presence of cirrhosis, and elevated AFP, Asian ethnicity and heavy cumulative tobacco use are strong independent predictors of HCC.
Similar content being viewed by others
Abbreviations
- RF:
-
Risk factors
- HCC:
-
Hepatocellular carcinoma
- HBV:
-
Hepatitis B virus
- HCV:
-
Hepatitis C virus
- DM:
-
Diabetes mellitus
- AFP:
-
Alpha-fetoprotein
- ALT:
-
Alanine aminotransferase
- AST:
-
Aspartate aminotransferase
- MELD:
-
Model for end-stage liver disease
- CTP:
-
Child-Turcotte-Pugh
References
Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2:533–543
Mazzanti R, Gramantieri L, Bolondi L (2008) Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med 29:130–143
El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576
Nguyen MH, Keeffe EB (2005) General management. Best Pract Res Clin Gastroenterol 19:161–174
Kanwal F, El-Serag HB (2009) Hepatocellular cancer care: cost is important but only one factor of disease burden. J Hepatol 50:10–12
Donato F, Tagger A, Gelatti U et al (2002) Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 155:323–331
Di Bisceglie AM, Lyra AC, Schwartz M et al (2003) Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol 98:2060–2063
Parkin DM (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030–3044
El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127:S27–S34
Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14:4300–4308
Nguyen MH, Whittemore AS, Garcia RT et al (2004) Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. Clin Gastroenterol Hepatol 2:820–824
Chin PL, Chu DZ, Clarke KG, Odom-Maryon T, Yen Y, Wagman LD (1999) Ethnic differences in the behavior of hepatocellular carcinoma. Cancer 85:1931–1936
Hassan MM, Hwang LY, Hatten CJ et al (2002) Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36:1206–1213
Mukaiya M, Nishi M, Miyake H, Hirata K (1998) Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases. Hepatogastroenterology 45:2328–2332
Chen ZM, Liu BQ, Boreham J, Wu YP, Chen JS, Peto R (2003) Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths. Int J Cancer 107:106–112
Mizoue T, Tokui N, Nishisaka K et al (2000) Prospective study on the relation of cigarette smoking with cancer of the liver and stomach in an endemic region. Int J Epidemiol 29:232–237
Tanaka K, Hirohata T, Takeshita S et al (1992) Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka. Jpn Int J Cancer 51:509–514
La Vecchia C, Negri E, Decarli A, D’Avanzo B, Franceschi S (1988) Risk factors for hepatocellular carcinoma in northern Italy. Int J Cancer 42:872–876
Evans AA, Chen G, Ross EA, Shen FM, Lin WY, London WT (2002) Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11:369–376
El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369–380
Chang KC, Tsai PS, Hsu MC, Hung SF, Tsai CC, Lu SN (2010) Chronic hepatitis C increased the mortality rates of patients with hepatocellular carcinoma and diabetes mellitus in a triple hepatitis virus endemic community. J Gastroenterol PMID:20054698
Pattullo V, Heathcote J (2009) Hepatitis C and diabetes: one treatment for two diseases? Liver Int PMID:20040049
Patel P, Macerollo A (2010) Diabetes mellitus: diagnosis and screening. Am Fam Physician 81:863–870
El-Serag HB (2007) Epidemiology of hepatocellular carcinoma in USA. Hepatol Res 37(Suppl 2):S88–S94
Kuper H, Tzonou A, Kaklamani E et al (2000) Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 85:498–502
Zhu K, Moriarty C, Caplan LS, Levine RS (2007) Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control 18:315–321
Jee SH, Ohrr H, Sull JW, Samet JM (2004) Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 96:1851–1856
Fujita Y, Shibata A, Ogimoto I et al (2006) The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 94:737–739
Wang LY, You SL, Lu SN et al (2003) Risk of hepatocellular carcinoma and habits of alcohol drinking, betel quid chewing and cigarette smoking: a cohort of 2416 HBsAg-seropositive and 9421 HBsAg-seronegative male residents in Taiwan. Cancer Causes Control 14:241–250
Hassan MM, Spitz MR, Thomas MB et al (2008) Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer 123:1883–1891
Wong CR, Garcia RT, Trinh HN et al (2009) Adherence to Screening for Hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting. Dig Dis Sci PMID:19876735
Conflict of interest
None to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ha, N.B., Ha, N.B., Ahmed, A. et al. Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study. Cancer Causes Control 23, 455–462 (2012). https://doi.org/10.1007/s10552-012-9895-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-012-9895-z